Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 1 · 33.3%High 0 · 0%

Dopamine agonist vs placebo or no intervention

Moderate or severe OHSS · women undergoing assisted reproduction

Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).

1 finding from 1 review

Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
OR 0.32 [0.23, 0.44]
10 studies · 1202 participants
Moderate

Dopamine agonist vs other active intervention

Moderate or severe OHSS · women undergoing assisted reproduction

It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).

1 finding from 1 review

Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
OR 0.21 [0.12, 0.38]
3 studies · 296 participants
Very low

Dopamine agonist plus co‐intervention vs co‐intervention

Moderate or severe OHSS · women undergoing assisted reproduction

Dopamine agonist plus co‐intervention may leads to lower incidence of moderate or severe OHSS compared with co‐intervention (low certainty).

1 finding from 1 review

Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
OR 0.48 [0.28, 0.84]
4 studies · 748 participants
Low